| __timestamp | Evotec SE | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 382096000000 |
| Thursday, January 1, 2015 | 18343000 | 345927000000 |
| Friday, January 1, 2016 | 18108000 | 312303000000 |
| Sunday, January 1, 2017 | 17614000 | 325441000000 |
| Monday, January 1, 2018 | 35619000 | 368298000000 |
| Tuesday, January 1, 2019 | 58432000 | 492381000000 |
| Wednesday, January 1, 2020 | 63945000 | 455833000000 |
| Friday, January 1, 2021 | 72200000 | 526087000000 |
| Saturday, January 1, 2022 | 76642000 | 633325000000 |
| Sunday, January 1, 2023 | 57519000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Takeda Pharmaceutical Company Limited and Evotec SE have been at the forefront of this race. Takeda, a Japanese powerhouse, has consistently outpaced its German counterpart, Evotec, in R&D spending. In 2023, Takeda's R&D expenses soared to a staggering 730 billion yen, marking a 91% increase since 2014. In contrast, Evotec's R&D investment grew by 364% over the same period, reaching 77 million euros in 2022. This disparity highlights Takeda's robust commitment to innovation, despite Evotec's impressive growth trajectory. However, 2024 data for Evotec remains elusive, leaving room for speculation on its future strategy. As these two giants continue to invest in groundbreaking research, the pharmaceutical landscape is set for exciting developments.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Takeda Pharmaceutical Company Limited vs Celldex Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Apellis Pharmaceuticals, Inc. and Evotec SE
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Evotec SE
R&D Spending Showdown: Geron Corporation vs Evotec SE